This information was published on 2026-04-27T09:06:24 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2641427 (IR 1910921) |
| (220) |
25 Feb 2026
|
| (300) |
DK, 24 Sep 2025, VA 2025 01582
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long-term weight loss maintenance. |
| (540) | Ayonzilo |
| (550) | Word |
| (730) |
Novo Nordisk A/S
|
Find out more about publications on the About page.